What is a High Mitotic Rate in GIST Pathology?

When reading your Gastrointestinal Stromal Tumor (GIST) pathology report, the mitotic rate tells you how fast the tumor cells are growing and dividing. Generally, a mitotic rate of 5 or lower is considered low and suggests a slower-growing tumor. A rate higher than 5 is considered high, which means the tumor is growing more aggressively and has a higher chance of spreading or returning after surgery ^[1][2].

Understanding Mitotic Rate

Mitotic rate refers to the speed at which cancer cells are actively dividing. When a pathologist examines your biopsy or tumor tissue under a microscope, they count the number of cells that are in the process of splitting into two new cells (a process called mitosis) ^[2]. A higher count means the cells are multiplying rapidly, which is a key sign of a more aggressive tumor ^[3]. The risk of the tumor returning increases progressively as the mitotic count rises further above the threshold of 5. Because calculating this rate can sometimes be subjective, getting a second opinion on your pathology report from a specialist is often recommended.

How is it Measured?

You will typically see the mitotic rate on your pathology report written as a number over a specific area.

• Per 50 HPF: Historically, pathologists counted dividing cells across 50 “High Power Fields” (the area visible under the microscope at high magnification). In this system, 5 mitoses per 50 HPF is the standard threshold for separating low-risk from higher-risk tumors ^[1][4].
• Per 5 mm²: Because different microscopes can have slightly different field sizes, medical guidelines increasingly prefer measuring the mitotic rate over a standardized area of 5 square millimeters (5 mm²). The threshold remains the same: a count over 5 per 5 mm² is considered high ^[5][6].

Why This Number Matters

The mitotic rate is one of the most important pieces of information your care team uses to determine your treatment plan ^[7][4]. However, it is never used alone. Doctors combine the mitotic rate with other key factors to assess your overall risk:

• Tumor size: Larger tumors generally carry a higher risk ^[8].
• Tumor location: GISTs starting in the stomach tend to have a better outlook than those starting in the small intestine or other areas, even if they have the same size and mitotic rate ^[9][10]. For example, a “high” mitotic rate in a stomach tumor might balance out to an intermediate risk, whereas the same rate in the small intestine might be classified as high risk.
• Tumor rupture: If the tumor ruptured (broke open) before or during surgery, it automatically places the tumor in a high-risk category, regardless of its size or mitotic rate.

By looking at all these factors together, your doctor can categorize your GIST into a specific risk group (such as very low, low, intermediate, or high risk) ^[2][7]. This combined assessment helps them decide if you need targeted medications after surgery, such as imatinib (Gleevec), to lower the chance of the tumor coming back.